Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X010526 | — |
Patient involved has not reported any medical concerns or symptoms/ No additional AE/PQC.; Expired dose of VARIVAX that was administered; This spontaneous report was received from a medical assistant, regarding a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. Concomitant medications included sterile diluent (BAXTER STERILE DILUENT) . On 21-Apr-2025, the patient was vaccinated with an expired dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) at a dose of 0.5 mL (Two dose series) as prophylaxis (lot number: X010526, which was determined to be valid, with an expiration date on 11-Apr-2025) (strength, scheme, route and anatomical location of administration were not reported) (Product use issue) The patient did not reported any medical concerns or symptoms/ No additional AE/PQC.
VARIVAX